Recruiting NCT06243393 ☆ Save
Phase II / Phase III Interventional Germany
Metastatic Colorectal Cancer
Not yet recruiting NCT06493448 ☆ Save
— Observational China
Gastric Cancer · Liver Metastases
Not yet recruiting NCT06492941 ☆ Save
Phase III Interventional —
Advanced Pancreatic Cancer
Recruiting NCT05462236 ☆ Save
Phase II Interventional Australia
Metastatic Colorectal Cancer
Recruiting NCT06491472 ☆ Save
Phase II Interventional China
Pancreatic Cancer
Recruiting NCT06492408 ☆ Save
Phase II Interventional China
Hepatic Cancer · Surgery
Not yet recruiting NCT06492317 ☆ Save
Phase II Interventional China
HER2-positive Gastric Cancer
Recruiting NCT06124456 ☆ Save
No phase Interventional Hong Kong
Obesity · NAFLD
Not yet recruiting NCT06491134 ☆ Save
Phase I Interventional —
Esophageal Squamous Cell Carcinoma
Not yet recruiting NCT06490198 ☆ Save
Phase I Interventional Taiwan
Cholangiocarcinoma · Chemotherapy Effect · Immunotherapy
Recruiting NCT06313567 ☆ Save
Phase III Interventional China
Gastric Cancer
Recruiting NCT06487663 ☆ Save
No phase Interventional China
Hepatocellular Carcinoma Non-resectable · Cholangiocarcinoma Non-resectable · Liver Metastases
Recruiting NCT06466902 ☆ Save
— Observational Italy
Gastric Cancer · Gastric Adenocarcinoma · Lymphadenectomy
Recruiting NCT06487429 ☆ Save
Phase II Interventional China
Gastric Cancer
Enrolling by invitation NCT06487312 ☆ Save
— Observational China
Ultrasound · Thyroid · Carotid Artery
Not yet recruiting NCT06487702 ☆ Save
Phase II Interventional China
Esophageal Squamous Cell Carcinoma
Recruiting NCT06485271 ☆ Save
— Observational China
Gastric Cancer · RWS · PD-1 Immunotherapy
Not yet recruiting NCT06484153 ☆ Save
Phase I / Phase II Interventional —
To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma · To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer · Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to Improve Patient Prognosis in Colorectal Cancer
Recruiting NCT06298968 ☆ Save
Phase II Interventional China
Intrahepatic Cholangiocarcinoma
Recruiting NCT06339060 ☆ Save
Phase III Interventional China
Esophageal Cancer
Recruiting NCT04520737 ☆ Save
No phase Interventional Spain
Prehabilitation · Neoadjuvant Therapy · Liver Metastases
Recruiting NCT06385730 ☆ Save
Phase II Interventional China
Esophageal Cancer
Recruiting NCT06482801 ☆ Save
Phase II Interventional China
Liver Cancer · Antibody
Not yet recruiting NCT06469060 ☆ Save
Phase II Interventional China
Esophageal Cancer
Recruiting NCT06482788 ☆ Save
Phase II Interventional China
Esophagogastric Junction Adenocarcinoma
Recruiting NCT06454448 ☆ Save
Phase I / Phase II Interventional China
Adebrelimab (SHR-1316) · Decitabine · Metastatic Pancreatic Cancer
Recruiting NCT06314646 ☆ Save
— Observational Italy
Rectal Cancer · Surgery
Not yet recruiting NCT06478264 ☆ Save
Phase II Interventional —
Esophageal Small Cell Carcinoma
Recruiting NCT06196697 ☆ Save
Phase II Interventional China
Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma
Recruiting NCT06477991 ☆ Save
— Observational China
Clinical Complete Response Rate With Negative MRD
Recruiting NCT06478927 ☆ Save
No phase Interventional China
Hepatocellular Carcinoma
Recruiting NCT03949231 ☆ Save
Phase III Interventional China
Liver Cancer
Recruiting NCT06385418 ☆ Save
Phase II Interventional China
Colorectal Cancer
Recruiting NCT03596476 ☆ Save
No phase Interventional France
Gastro-esophageal Reflux Disease
Recruiting NCT04803318 ☆ Save
Phase II Interventional China
Solid Tumor, Adult · Hepatocellular Carcinoma
Recruiting NCT06359275 ☆ Save
Phase II Interventional China
Pancreatic Cancer
Not yet recruiting NCT06470178 ☆ Save
— Observational China
Colorectal Cancer
Recruiting NCT06390878 ☆ Save
No phase Interventional Finland
Microbial Colonization · Atopic Dermatitis · Asthma in Children
Not yet recruiting NCT05498766 ☆ Save
Phase IV Interventional China
Gastric Cancer
Recruiting NCT06341335 ☆ Save
Phase III Interventional China
Gastric and Gastroesophageal Junction Adenocarcinoma
Recruiting NCT06470256 ☆ Save
Phase I Interventional China
Advanced Hepatocellular Carcinoma
Recruiting NCT06161207 ☆ Save
Phase III Interventional China
Gastric Cancer · Surgery
Not yet recruiting NCT06468670 ☆ Save
Phase II Interventional —
Esophageal Squamous Cell Carcinoma
Not yet recruiting NCT06468488 ☆ Save
No phase Interventional Belgium
Breast Reconstruction
Not yet recruiting NCT06468644 ☆ Save
Phase II Interventional —
Esophageal Squamous Cell Carcinoma
Recruiting NCT06469593 ☆ Save
No phase Interventional Denmark
Diabetes Mellitus, Type 1
Not yet recruiting NCT06468969 ☆ Save
No phase Interventional —
Gastric Cancer · Total Gastrectomy · Postoperative Care
Enrolling by invitation NCT05877456 ☆ Save
— Observational Belgium
Colorectal Adenoma · Colorectal Polyp · Colo-rectal Cancer
Recruiting NCT06466707 ☆ Save
No phase Interventional Belgium
Microbial Colonization
Recruiting NCT06147635 ☆ Save
Phase II Interventional Netherlands
Acute Pancreatitis
Recruiting NCT04340986 ☆ Save
— Observational France
Cholangiocarcinoma · Hepatocellular Carcinoma
Recruiting NCT02864485 ☆ Save
No phase Interventional Canada
Colorectal Cancer · Liver Metastases
Not yet recruiting NCT06464601 ☆ Save
— Observational China
Gastric Cancer
Not yet recruiting NCT06463548 ☆ Save
No phase Interventional China
Biliary Tract Carcinoma
Recruiting NCT06463834 ☆ Save
Phase II Interventional China
Esophageal Squamous Cell Carcinoma
Recruiting NCT06462053 ☆ Save
Phase II Interventional China
Early Low Rectal Cancer
Recruiting NCT05701241 ☆ Save
Phase IV Interventional Belgium, Netherlands
Gastroenteropancreatic Neuroendocrine Tumor
Recruiting NCT04050345 ☆ Save
— Observational United Kingdom
Colorectal Cancer
Recruiting NCT06084897 ☆ Save
Phase II Interventional China
Esophageal Neoplasm Metastatic · Esophageal Cancer Stage IVb
Not yet recruiting NCT06460896 ☆ Save
No phase Interventional France
Bypass Bariatric Surgery
Recruiting NCT05257746 ☆ Save
— Observational Germany
Rectal Surgery
Recruiting NCT06253650 ☆ Save
Phase II Interventional Italy
Gastric Cancer · HER2-positive Gastric Cancer
Recruiting NCT06455124 ☆ Save
Phase II Interventional China
Rectal Cancer
Recruiting NCT04678583 ☆ Save
No phase Interventional Germany
Colorectal Liver Metastasis
Not yet recruiting NCT06454435 ☆ Save
Phase II Interventional China
Gastric Cancer · Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma
Not yet recruiting NCT06455501 ☆ Save
— Observational —
Rectal Prolapse
Recruiting NCT06451393 ☆ Save
— Observational China
Gastric Cancer · Chemotherapy Effect
Recruiting NCT06451211 ☆ Save
Phase II Interventional China
Stomach Neoplasms · Gastric Cancer · Linitis Plastica of Stomach
Recruiting NCT06452966 ☆ Save
No phase Interventional Taiwan
Organ Failure, Multiple · Indigestion · Delayed Gastric Emptying
Recruiting NCT06449833 ☆ Save
Phase IV Interventional China
Type2 Diabetes Mellitus · Nonalcoholic Fatty Liver Disease
Recruiting NCT06449937 ☆ Save
No phase Interventional China
Metastatic Colorectal Carcinoma · Multi-organ Metastatic Colorectal Cancer · Metastatic Malignant Neoplasm in the Liver
Not yet recruiting NCT06450574 ☆ Save
Phase III Interventional —
Rectal Cancer Stage I
Not yet recruiting NCT06449846 ☆ Save
— Observational China
Hepatocellular Carcinoma Resectable · Surgery · Recurrence
Recruiting NCT06018896 ☆ Save
Phase II Interventional China
Metastatic Pancreatic Cancer · Terminal Cancer
Recruiting NCT04891016 ☆ Save
Phase II Interventional China
Chemotherapy · Immune Checkpoint Inhibitor · Locally Advanced Gastric Carcinoma
Enrolling by invitation NCT05287737 ☆ Save
— Observational Netherlands
Islets of Langerhans Transplantation · Pancreatitis, Chronic · Diabetes Mellitus
Recruiting NCT06446050 ☆ Save
Early Phase I Interventional China
Advanced Colorectal Cancer
Not yet recruiting NCT06446908 ☆ Save
No phase Interventional —
Liver Steatosis · MASH · MASLD
Enrolling by invitation NCT06443996 ☆ Save
— Observational China
Colorectal Cancer · Sleep Quality · Mental Status Change
Not yet recruiting NCT06443671 ☆ Save
Phase II / Phase III Interventional China
Rectal Cancer
Recruiting NCT05304234 ☆ Save
Phase II Interventional United States
Hepatocellular Carcinoma · Cirrhosis, Liver · Hepatitis B
Recruiting NCT06440902 ☆ Save
Phase II Interventional China
Colorectal Cancer Metastatic
Recruiting NCT05309863 ☆ Save
— Observational Belgium
Pediatric Non-alcoholic Fatty Liver Disease
Not yet recruiting NCT06275997 ☆ Save
No phase Interventional —
Gastric Cancer
Recruiting NCT03349762 ☆ Save
— Observational China
Colorectal Cancer
Not yet recruiting NCT06439550 ☆ Save
Phase II Interventional —
HER2-positive Gastric Cancer
Not yet recruiting NCT06435689 ☆ Save
— Observational France
Colon Cancer · Peritoneal Carcinoma
Not yet recruiting NCT06364462 ☆ Save
— Observational —
NASH · Liver Fibrosis
Recruiting NCT06415669 ☆ Save
Phase II Interventional China
Gastric/Gastroesophageal Junction Adenocarcinoma
Not yet recruiting NCT06432075 ☆ Save
Early Phase I Interventional —
Advanced Gastric Cancer
Recruiting NCT06429839 ☆ Save
Phase II Interventional China
Esophageal Cancer · Nimotuzumab · Chemoradiotherapy
Not yet recruiting NCT06405958 ☆ Save
— Observational —
Microbial Colonization
Recruiting NCT05911217 ☆ Save
Phase I Interventional China
Pancreatic Cancer
Not yet recruiting NCT06426654 ☆ Save
Phase I / Phase II Interventional —
Gastric Cancer
Recruiting NCT06427460 ☆ Save
Phase II Interventional China
Pancreatic Cancer
Not yet recruiting NCT06426797 ☆ Save
Phase II Interventional —
Locally Advanced Esophageal Squamous Cell Carcinoma
Recruiting NCT05536089 ☆ Save
— Observational China
Cancer Colorectal
Recruiting NCT06420700 ☆ Save
— Observational United States
Obesity
Recruiting NCT02920554 ☆ Save
No phase Interventional South Korea
Gallbladder Cancer
Recruiting NCT06204835 ☆ Save
Phase I Interventional China
Hepatocellular Carcinoma